KATHERINE clinical trial update: Kadcyla precision cancer medicine improves survival in HER2 + early stage breast cancer
Maintenance therapy prolongs survival in lymphoma, leukemia, myeloma, sarcoma, ovarian and other types of cancer.
Update on Rx of Hot Flashes from San Antonio Meetings. Oxybutinim, Anit-depressants, Acupuncture and more.
The c-Met inhibitor Capmatinib is a promising novel precision cancer medicine for the treatment of EGFR + NSCLC.
Xtandi® prostate cancer treatment Improves survival in metastatic and non-metastatic prostate cancer with rising PSA
Breast cancer surgeon Dr. Kirstein of MSKCC is taking questions about the management of high risk breast caner this week
ASH Highlights Blincyto, REGN1979 and AMG420 BiTE® antibody immunotherapy for lymphomas and myeloma.
Fatigue and Cancer go hand in hand - learn what you can do to help overcome being tired.
Understand the administration, side effects and answers to frequently asked questions about Xtandi® (Enzalutamide)
DCVAax trial update provided-still looks promising:
Can very high dose radiation cure metastatic cancer?
HER 2 + Lung Cancer Treatment?
"some evidence" that cell phones cause brain tumors in rats;
Is Adavosertib ready for sarcoma clinical trials?
Interesting data published this week show HDC appears to benefit TNBC:
New Antibody that targets CD74 on myeloma cells gets nod from FDA to proceed.
Long-Term Follow-Up Indicates Continued Improvement in Survival with Addition of Rituxan® to CHOP in NHL
Should the blood biopsy replace the tissue biopsy?
